New hope for young hodgkin lymphoma patients with customized treatment plan
NCT ID NCT03755804
Summary
This study is testing different combinations of chemotherapy drugs for children and young adults with Hodgkin lymphoma, based on how advanced their cancer is. The goal is to control the disease and prevent it from coming back. Doctors will also closely monitor side effects and the patients' long-term health after treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Lucile Packard Children's Hospital Stanford University
Palo Alto, California, 94304, United States
-
Maine Children's Cancer Program
Scarborough, Maine, 04074, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
St. Jude Affiliate Baton Rouge Clinic (Our Lady of the Lakes Regional Medical Center)
Baton Rouge, Louisiana, 70809, United States
-
St. Jude Affiliate Clinic at Novant Health Hemby Children's Hospital
Charlotte, North Carolina, 28204, United States
-
St. Jude Children's Research Hospital
Memphis, Tennessee, 38105, United States
-
St. Jude Midwest Affiliate - Peoria
Peoria, Illinois, 61637, United States
Conditions
Explore the condition pages connected to this study.